Patients with penetrating eye injuries, and patients undergoing emergency ophthalmic surgery in whom intraocular pressure (IOP) is increased may lose intraocular contents-especially at the time of tracheal intubation. Techniques such as precurarization, or the use of non-depolarizing neuromuscular blocking drugs have been advocated to overcome this problem.
Patients with penetrating eye injuries, and patients undergoing emergency ophthalmic surgery in whom intraocular pressure (IOP) is increased may lose intraocular contents-especially at the time of tracheal intubation. Techniques such as precurarization, or the use of non-depolarizing neuromuscular blocking drugs have been advocated to overcome this problem.
Etomidate is a short-acting non-barbiturate i.v. anaesthetic agent. Its administration is associated with cardiovascular stability and only minimal respiratory depression. The untoward effects of etomidate are involuntary muscle movements and pain at the site of injection. It decreases intraocular pressure (Oji and Holdcroft, 1979) . Thiopentone also decreases intraocular pressure. The present study was undertaken to compare the decreases in IOP associated with the use of thiopentone or etomidate.
PATIENTS AND METHODS
Fifty patients of either sex (aged 14 yr and above) undergoing elective non-ophthalmic surgery were studied. The patients were selected at random. The procedure was explained in detail and informed consent obtained.
Atropine sulphate 0.6 mg i.m. was given 45 min before the induction of anaesthesia. Lignocaine hydrochloride 4% was instilled to both eyes before induction and IOP was recorded in both eyes (Schiotz Tonometer). Patients were then allotted to receive either thiopentone 4-5 mg kg" 1 (n = 25) or etomidate 0.3 mg kg" 1 (n = 25) at random. IOP was measured at 1,2 and 3 min after the administration of the induction agent. Antibiotic eye drops (Vanmycetin) were instilled to both the eyes and the eyes covered with sterile cotton pads. Systolic arterial pressure was measured before and after induction. Suxamethonium 1-2 mg kg" 1 was then given and the trachea intubated under direct vision. Anaesthesia was maintained with 70 % nitrous oxide in oxygen.
SUMMARY
Patients were observed for 24 h after operation. They were asked about any irritation in the eyes, or excessive watering of the eyes. Eyes were examined for any redness or corneal abrasions.
Statistical analysis was by t test.
RESULTS
There were comparable decreases in systolic arterial pressure, after induction, in both groups. In the group receiving etomidate, systolic arterial pressure decreased from 128 ±16 (mean±SD) mm Hg to 118±13mmHg. In the thiopentone group the systolic arterial pressure decreased from 122±27mmHgto 116± 19 mm Hg (table I) . IOP decreased, in the etomidate group, from 15.9 (±1.3)mmHg (mean±SD) to 7.9± 1.0 mm Hg, and remained low until the suxamethonium was given (table II) . A similar mean decrease in IOP was noted in the thiopentone group (from 15.3±1.4mmHg to 10.0 + 1.8mmHg), and this was maintained at the 2nd and 3rd min (table II) . The decrease in IOP attributable to etomidate was significantly greater than that associated with thiopentone.
Pupillary changes were seen immediately after the administration of the etomidate. Initial dilatation of the pupils was followed by constriction. No ophthalmic complications were encountered in the 24 h following the procedure.
DISCUSSION
Various factors can alter IOP during anaesthesia. Atropine was the only premedication given to the patients because it does not produce any change in IOP (Eakin and Katz, 1966) . Oji and Holdcroft (1969) studied the effects of etomidate on IOP and suggested that the observed decrease in IOP could be the result of the accompanying decrease in the systolic arterial pressure. In the present study the decreases in systolic arterial pressure associated with the administration of thiopentone or etomidate were not significant (P < 0.01). However, the decreases in IOP obtained in the present study were significant (P < 0.001). Moreover, the decrease produced by etomidate was significantly greater than that produced by thiopentone. Oji and Holdcroft (1969) suggested that the decrease in IOP associated with etomidate (which occurred after 1 min) was primarily the result of an action involving the facilitation of aqueous outflow. We support the possibility of such a mechanism, although a controlled study involving the use of a drug blocking aqueous outflow would be required to confirm this hypothesis.
Thompson and colleagues (1982) also reported a decrease in IOP with etomidate and highlighted the possible influences of central venous pressure, systolic arterial pressure and arterial carbon dioxide tension. The effect of these factors is largely mediated through variations in choroidal blood flow. They also suggested that a secondary action on the production of the aqueous fluid could decrease IOP. However, we believe that such a secondary effect is unlikely to be an important mechanism in the reduction of intraocular pressure because the effects were seen rapidly (within 1 min of the administration of the etomidate). A similar decrease in IOP was seen following the administration of the thiopentone (P < 0.001). However, the mean decrease was less than that associated with etomidate. Rubin and Esente (1950) suggested that this decrease in IOP could result from the action of thiopentone on the ocular centre in the diencephalon. We agree more with Duncalf and Weitzner (1963) , who suggested that an increase in the outflow of aqueous humor, relaxation of extraocular muscles and peripheral vasodilatation could be the factors causing the decrease in IOP.
Involuntary muscle movements caused by etomidate did not interfere with measurements of IOP. A large vein was used for the administration of etomidate and this reduced the frequency of pain at the site of injection. We made no attempt to determine whether the increase in intraocular pressure, associated with the administration of suxamethonium, was obtunded following the administration of the etomidate or thiopentone. However, it would have been worthwhile considering this point since it would be clinically useful to know whether the initial decrease in intraocular pressure, produced by the ctomidate or thiopentone, obtunded, or minimized, the increase in intraocular pressure which usually accompanies the administration of suxamethonium.
